Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 402

1.

Genetic regulatory variation in populations informs transcriptome analysis in rare disease.

Mohammadi P, Castel SE, Cummings BB, Einson J, Sousa C, Hoffman P, Donkervoort S, Jiang Z, Mohassel P, Foley AR, Wheeler HE, Im HK, Bonnemann CG, MacArthur DG, Lappalainen T.

Science. 2019 Oct 18;366(6463):351-356. doi: 10.1126/science.aay0256. Epub 2019 Oct 10.

PMID:
31601707
2.

Transcriptome association studies of neuropsychiatric traits in African Americans implicate PRMT7 in schizophrenia.

Fiorica PN, Wheeler HE.

PeerJ. 2019 Sep 26;7:e7778. doi: 10.7717/peerj.7778. eCollection 2019.

3.

Genetically regulated gene expression underlies lipid traits in Hispanic cohorts.

Andaleon A, Mogil LS, Wheeler HE.

PLoS One. 2019 Aug 8;14(8):e0220827. doi: 10.1371/journal.pone.0220827. eCollection 2019.

4.

Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.

Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC Jr, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME.

Clin Cancer Res. 2019 Oct 1;25(19):5913-5924. doi: 10.1158/1078-0432.CCR-19-0113. Epub 2019 Jul 11.

PMID:
31296530
5.

Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma.

Back MF, Jayamanne D, Back E, Kastelan M, Khasraw M, Wong M, Brown C, Wheeler H.

Cancer. 2019 Oct 1;125(19):3457-3466. doi: 10.1002/cncr.32352. Epub 2019 Jun 28.

PMID:
31251406
6.

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.

Cuncannon M, Wong M, Jayamanne D, Guo L, Cove N, Wheeler H, Back M.

BMC Cancer. 2019 May 14;19(1):445. doi: 10.1186/s12885-019-5678-1.

7.

Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation.

Back M, Jayamanne D, Brazier D, Newey A, Bailey D, Schembri G, Hsiao E, Khasraw M, Wong M, Kastelan M, Brown C, Wheeler H.

Strahlenther Onkol. 2019 Apr 26. doi: 10.1007/s00066-019-01467-0. [Epub ahead of print]

PMID:
31028406
8.

Rewilding complex ecosystems.

Perino A, Pereira HM, Navarro LM, Fernández N, Bullock JM, Ceaușu S, Cortés-Avizanda A, van Klink R, Kuemmerle T, Lomba A, Pe'er G, Plieninger T, Rey Benayas JM, Sandom CJ, Svenning JC, Wheeler HC.

Science. 2019 Apr 26;364(6438). pii: eaav5570. doi: 10.1126/science.aav5570. Review.

PMID:
31023897
9.

Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.

El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC Jr, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME.

Clin Cancer Res. 2019 Jul 1;25(13):4104-4116. doi: 10.1158/1078-0432.CCR-18-3179. Epub 2019 Apr 5.

PMID:
30952644
10.

Imputed gene associations identify replicable trans-acting genes enriched in transcription pathways and complex traits.

Wheeler HE, Ploch S, Barbeira AN, Bonazzola R, Andaleon A, Fotuhi Siahpirani A, Saha A, Battle A, Roy S, Im HK.

Genet Epidemiol. 2019 Sep;43(6):596-608. doi: 10.1002/gepi.22205. Epub 2019 Apr 4.

11.

Weak effects of geolocators on small birds: A meta-analysis controlled for phylogeny and publication bias.

Brlík V, Koleček J, Burgess M, Hahn S, Humple D, Krist M, Ouwehand J, Weiser EL, Adamík P, Alves JA, Arlt D, Barišić S, Becker D, Belda EJ, Beran V, Both C, Bravo SP, Briedis M, Chutný B, Ćiković D, Cooper NW, Costa JS, Cueto VR, Emmenegger T, Fraser K, Gilg O, Guerrero M, Hallworth MT, Hewson C, Jiguet F, Johnson JA, Kelly T, Kishkinev D, Leconte M, Lislevand T, Lisovski S, López C, McFarland KP, Marra PP, Matsuoka SM, Matyjasiak P, Meier CM, Metzger B, Monrós JS, Neumann R, Newman A, Norris R, Pärt T, Pavel V, Perlut N, Piha M, Reneerkens J, Rimmer CC, Roberto-Charron A, Scandolara C, Sokolova N, Takenaka M, Tolkmitt D, van Oosten H, Wellbrock AHJ, Wheeler H, van der Winden J, Witte K, Woodworth BK, Procházka P.

J Anim Ecol. 2019 Feb 16. doi: 10.1111/1365-2656.12962. [Epub ahead of print]

PMID:
30771254
12.

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.

Back M, Jayamanne DT, Brazier D, Newey A, Bailey D, Schembri GP, Hsiao E, Khasraw M, Wong M, Kastelan M, Guo L, Clarke S, Wheeler H.

J Med Imaging Radiat Oncol. 2019 Apr;63(2):272-280. doi: 10.1111/1754-9485.12850. Epub 2019 Jan 24.

PMID:
30677248
13.

Integrating predicted transcriptome from multiple tissues improves association detection.

Barbeira AN, Pividori M, Zheng J, Wheeler HE, Nicolae DL, Im HK.

PLoS Genet. 2019 Jan 22;15(1):e1007889. doi: 10.1371/journal.pgen.1007889. eCollection 2019 Jan.

14.

Chronic circadian misalignment results in reduced longevity and large-scale changes in gene expression in Drosophila.

Boomgarden AC, Sagewalker GD, Shah AC, Haider SD, Patel P, Wheeler HE, Dubowy CM, Cavanaugh DJ.

BMC Genomics. 2019 Jan 7;20(1):14. doi: 10.1186/s12864-018-5401-7.

15.

Anti-angiogenic therapy for high-grade glioma.

Ameratunga M, Pavlakis N, Wheeler H, Grant R, Simes J, Khasraw M.

Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218. doi: 10.1002/14651858.CD008218.pub4.

PMID:
30480778
16.

Identifying key needs for the integration of social-ecological outcomes in arctic wildlife monitoring.

Wheeler HC, Berteaux D, Furgal C, Cazelles K, Yoccoz NG, Grémillet D.

Conserv Biol. 2019 Aug;33(4):861-872. doi: 10.1111/cobi.13257. Epub 2019 Jan 25.

PMID:
30471146
17.

Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma.

Back M, Jayamanne D, Brazier D, Bailey D, Hsiao E, Guo L, Wheeler H.

J Clin Neurosci. 2019 Jan;59:68-74. doi: 10.1016/j.jocn.2018.11.005. Epub 2018 Nov 14.

PMID:
30446361
18.

Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre.

Back M, Jayamanne D, Cove N, Wheeler H, Khasraw M, Guo L, Back J, Wong M.

Brain Sci. 2018 Oct 15;8(10). pii: E186. doi: 10.3390/brainsci8100186.

19.

FET PET in the evaluation of indeterminate brain lesions on MRI: Differentiating glioma from other non-neoplastic causes - A pilot study.

Chan DL, Hsiao E, Schembri G, Bailey DL, Roach PJ, Lee A, Jayamanne D, Ghasemzadeh M, Hayes A, Cook R, Parkinson J, Drummond JP, Ibbett I, Wheeler HR, Back M.

J Clin Neurosci. 2018 Dec;58:130-135. doi: 10.1016/j.jocn.2018.09.009. Epub 2018 Sep 19.

PMID:
30243602
20.

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment.

Hudson AL, Parker NR, Khong P, Parkinson JF, Dwight T, Ikin RJ, Zhu Y, Chen J, Wheeler HR, Howell VM.

Front Oncol. 2018 Aug 13;8:314. doi: 10.3389/fonc.2018.00314. eCollection 2018.

21.

Genetic architecture of gene expression traits across diverse populations.

Mogil LS, Andaleon A, Badalamenti A, Dickinson SP, Guo X, Rotter JI, Johnson WC, Im HK, Liu Y, Wheeler HE.

PLoS Genet. 2018 Aug 10;14(8):e1007586. doi: 10.1371/journal.pgen.1007586. eCollection 2018 Aug.

22.

VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites.

Kumar N, Leonzino M, Hancock-Cerutti W, Horenkamp FA, Li P, Lees JA, Wheeler H, Reinisch KM, De Camilli P.

J Cell Biol. 2018 Oct 1;217(10):3625-3639. doi: 10.1083/jcb.201807019. Epub 2018 Aug 9.

23.

Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function.

Wyss AB, Sofer T, Lee MK, Terzikhan N, Nguyen JN, Lahousse L, Latourelle JC, Smith AV, Bartz TM, Feitosa MF, Gao W, Ahluwalia TS, Tang W, Oldmeadow C, Duan Q, de Jong K, Wojczynski MK, Wang XQ, Noordam R, Hartwig FP, Jackson VE, Wang T, Obeidat M, Hobbs BD, Huan T, Gui H, Parker MM, Hu D, Mogil LS, Kichaev G, Jin J, Graff M, Harris TB, Kalhan R, Heckbert SR, Paternoster L, Burkart KM, Liu Y, Holliday EG, Wilson JG, Vonk JM, Sanders JL, Barr RG, de Mutsert R, Menezes AMB, Adams HHH, van den Berge M, Joehanes R, Levin AM, Liberto J, Launer LJ, Morrison AC, Sitlani CM, Celedón JC, Kritchevsky SB, Scott RJ, Christensen K, Rotter JI, Bonten TN, Wehrmeister FC, Bossé Y, Xiao S, Oh S, Franceschini N, Brody JA, Kaplan RC, Lohman K, McEvoy M, Province MA, Rosendaal FR, Taylor KD, Nickle DC, Williams LK, Burchard EG, Wheeler HE, Sin DD, Gudnason V, North KE, Fornage M, Psaty BM, Myers RH, O'Connor G, Hansen T, Laurie CC, Cassano PA, Sung J, Kim WJ, Attia JR, Lange L, Boezen HM, Thyagarajan B, Rich SS, Mook-Kanamori DO, Horta BL, Uitterlinden AG, Im HK, Cho MH, Brusselle GG, Gharib SA, Dupuis J, Manichaikul A, London SJ.

Nat Commun. 2018 Jul 30;9(1):2976. doi: 10.1038/s41467-018-05369-0.

24.

Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.

Jayamanne D, Wheeler H, Brazier D, Newey A, Kastelan M, Guo L, Back M.

Radiat Oncol. 2018 Jul 20;13(1):133. doi: 10.1186/s13014-018-1078-y.

25.

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial.

Lassman AB, van den Bent MJ, Gan HK, Reardon DA, Kumthekar P, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Ansell PJ, Bain E, Holen KD, Maag D, Merrell R.

Neuro Oncol. 2019 Jan 1;21(1):106-114. doi: 10.1093/neuonc/noy091.

26.

Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma.

Back M, Rodriguez M, Jayamanne D, Khasraw M, Lee A, Wheeler H.

Clin Oncol (R Coll Radiol). 2018 Sep;30(9):556-562. doi: 10.1016/j.clon.2018.06.005. Epub 2018 Jul 3. Review.

PMID:
29980381
27.

ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.

Lee A, Howell VM, Itchins M, Wheeler HR, Pavlakis N.

Clin Lung Cancer. 2018 Sep;19(5):457-459. doi: 10.1016/j.cllc.2018.05.015. Epub 2018 Jun 5. No abstract available.

PMID:
29945753
28.

The development of a district nursing caseload review tool.

Grundy C, Wheeler H.

Br J Community Nurs. 2018 Jun 2;23(6):272-278. doi: 10.12968/bjcn.2018.23.6.272.

PMID:
29869909
29.

The development of a district nursing caseload review tool.

Grundy C, Wheeler H.

Br J Community Nurs. 2018 Jun 2;23(6):220-226. doi: 10.12968/bjcn.2018.23.6.220.

PMID:
29799777
30.

Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity.

Li R, Kim D, Wheeler HE, Dudek SM, Dolan ME, Ritchie MD.

Pharmacogenomics J. 2019 Apr;19(2):178-190. doi: 10.1038/s41397-018-0024-6. Epub 2018 May 25.

PMID:
29795408
31.

Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics.

Barbeira AN, Dickinson SP, Bonazzola R, Zheng J, Wheeler HE, Torres JM, Torstenson ES, Shah KP, Garcia T, Edwards TL, Stahl EA, Huckins LM; GTEx Consortium, Nicolae DL, Cox NJ, Im HK.

Nat Commun. 2018 May 8;9(1):1825. doi: 10.1038/s41467-018-03621-1.

32.

Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.

Hayes AR, Jayamanne D, Hsiao E, Schembri GP, Bailey DL, Roach PJ, Khasraw M, Newey A, Wheeler HR, Back M.

Pract Radiat Oncol. 2018 Jul - Aug;8(4):230-238. doi: 10.1016/j.prro.2018.01.006. Epub 2018 Jan 31.

PMID:
29730279
33.

Music and Speech Perception in Children Using Sung Speech.

Nie Y, Galvin JJ 3rd, Morikawa M, André V, Wheeler H, Fu QJ.

Trends Hear. 2018 Jan-Dec;22:2331216518766810. doi: 10.1177/2331216518766810.

34.

Light-activated protein interaction with high spatial subcellular confinement.

Benedetti L, Barentine AES, Messa M, Wheeler H, Bewersdorf J, De Camilli P.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2238-E2245. doi: 10.1073/pnas.1713845115. Epub 2018 Feb 20.

35.

Gene-based association study for lipid traits in diverse cohorts implicates BACE1 and SIDT2 regulation in triglyceride levels.

Andaleon A, Mogil LS, Wheeler HE.

PeerJ. 2018 Jan 29;6:e4314. doi: 10.7717/peerj.4314. eCollection 2018.

36.

Clinical Question: In post-partum first-time mothers, what interventions are successful for helping women sustain exclusive breast feeding for one month or more?

Nguyen MT, Snow G, Wheeler H, Owens T.

J Okla State Med Assoc. 2016 Nov;109(11):521-4. Review. No abstract available.

37.

Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial.

Field KM, Fitt G, Rosenthal MA, Simes J, Nowak AK, Barnes EH, Sawkins K, Goh C, Moffat BA, Salinas S, Cher L, Wheeler H, Hovey EJ, Phal PM; CABARET/COGNO Investigators.

Asia Pac J Clin Oncol. 2018 Oct;14(5):e359-e365. doi: 10.1111/ajco.12806. Epub 2017 Nov 8.

PMID:
29114999
38.

Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.

Gan HK, Reardon DA, Lassman AB, Merrell R, van den Bent M, Butowski N, Lwin Z, Wheeler H, Fichtel L, Scott AM, Gomez EJ, Fischer J, Mandich H, Xiong H, Lee HJ, Munasinghe WP, Roberts-Rapp LA, Ansell PJ, Holen KD, Kumthekar P.

Neuro Oncol. 2018 May 18;20(6):838-847. doi: 10.1093/neuonc/nox202.

39.

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study.

van den Bent M, Gan HK, Lassman AB, Kumthekar P, Merrell R, Butowski N, Lwin Z, Mikkelsen T, Nabors LB, Papadopoulos KP, Penas-Prado M, Simes J, Wheeler H, Walbert T, Scott AM, Gomez E, Lee HJ, Roberts-Rapp L, Xiong H, Bain E, Ansell PJ, Holen KD, Maag D, Reardon DA.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1209-1217. doi: 10.1007/s00280-017-3451-1. Epub 2017 Oct 26.

40.

Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.

Jaymanne DT, Kaushal S, Chan D, Schembri G, Brazier D, Bailey D, Wheeler H, Back M.

J Med Imaging Radiat Oncol. 2018 Feb;62(1):122-127. doi: 10.1111/1754-9485.12676. Epub 2017 Oct 5.

PMID:
28980392
41.

Leptomeningeal melanoma-A case series in the era of modern systemic therapy.

Arasaratnam M, Hong A, Shivalingam B, Wheeler H, Guminksi AD, Long GV, Menzies AM.

Pigment Cell Melanoma Res. 2018 Jan;31(1):120-124. doi: 10.1111/pcmr.12652. Epub 2017 Oct 17. No abstract available.

PMID:
28976629
42.

Survival improvements with adjuvant therapy in patients with glioblastoma.

Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G, Kastelan M, Guo L, Back MF.

ANZ J Surg. 2018 Mar;88(3):196-201. doi: 10.1111/ans.14153. Epub 2017 Sep 18.

PMID:
28922698
43.

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial.

Hovey EJ, Field KM, Rosenthal MA, Barnes EH, Cher L, Nowak AK, Wheeler H, Sawkins K, Livingstone A, Phal P, Goh C, Simes J; CABARET/COGNO investigators.

Neurooncol Pract. 2017 Sep;4(3):171-181. doi: 10.1093/nop/npw025. Epub 2017 May 25.

44.

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.

van den Bent MJ, Baumert B, Erridge SC, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, Clement PM, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Brachman DG, Taal W, Rudà R, Weller M, McBain C, Reijneveld J, Enting RH, Weber DC, Lesimple T, Clenton S, Gijtenbeek A, Pascoe S, Herrlinger U, Hau P, Dhermain F, van Heuvel I, Stupp R, Aldape K, Jenkins RB, Dubbink HJ, Dinjens WNM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, Wick W, Kros JM.

Lancet. 2017 Oct 7;390(10103):1645-1653. doi: 10.1016/S0140-6736(17)31442-3. Epub 2017 Aug 8. Erratum in: Lancet. 2017 Oct 7;390(10103):1644.

45.

Wildlife species benefitting from a greener Arctic are most sensitive to shrub cover at leading range edges.

Wheeler HC, Høye TT, Svenning JC.

Glob Chang Biol. 2018 Jan;24(1):212-223. doi: 10.1111/gcb.13837. Epub 2017 Sep 5.

PMID:
28731522
46.

Comprehensive Multiphase (CMP) NMR Monitoring of the Structural Changes and Molecular Flux Within a Growing Seed.

Fortier-McGill BE, Dutta Majumdar R, Lam L, Soong R, Liaghati-Mobarhan Y, Sutrisno A, de Visser R, Simpson MJ, Wheeler HL, Campbell M, Gorissen A, Simpson AJ.

J Agric Food Chem. 2017 Aug 16;65(32):6779-6788. doi: 10.1021/acs.jafc.7b02421. Epub 2017 Aug 7.

PMID:
28727919
47.

The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET).

Field KM, Phal PM, Fitt G, Goh C, Nowak AK, Rosenthal MA, Simes J, Barnes EH, Sawkins K, Cher LM, Hovey EJ, Wheeler H.

Cancer. 2017 Sep 15;123(18):3576-3582. doi: 10.1002/cncr.30838. Epub 2017 Jul 5.

48.

Application of stem cell derived neuronal cells to evaluate neurotoxic chemotherapy.

Wing C, Komatsu M, Delaney SM, Krause M, Wheeler HE, Dolan ME.

Stem Cell Res. 2017 Jul;22:79-88. doi: 10.1016/j.scr.2017.06.006. Epub 2017 Jun 15.

49.

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.

Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB; Platinum Study Group.

Clin Cancer Res. 2017 Oct 1;23(19):5757-5768. doi: 10.1158/1078-0432.CCR-16-3224. Epub 2017 Jun 13.

50.

Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.

Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005.

Supplemental Content

Loading ...
Support Center